Skip to main content scroll back to top of page

Chimerix is now part of Jazz Pharmaceuticals. Learn more at www.jazzpharma.com

Chimerix Logo

Utility Navigation

  • Careers
Chimerix Logo

Primary Navigation

Close Menu
  • Pipeline
    • Our Pipeline
      Our PipelineOur Pipeline

      Oncology: Imipridones

      • ONC201 dordaviprone for gliomas
      • ONC206 for central nervous system tumors
      • ONC212 IND-enabling studies
      PublicationsPresentationsNeuro Oncology Publications2024 SNO Annual Conference
  • Company
    • Who We Are
    • Collaborations
    • Senior Management Team
    • Careers
  • Patients
    • Expanded Access
    • Clinical Trials
  • Products
    • TEMBEXA®
  • Investors
    • Overview
    • Press Releases
    • Presentations
    • Financials & Filings
    • Request Information
  • Contact

Privacy Notice

Last Modified: October 31, 2023

CHIMERIX PRIVACY NOTICE


Chimerix Logo
  • Chimerix on LinkedIn
  • Chimerix on Twitter

Legal Menu

  • Privacy Notice
  • Cookie Notice 
  • Terms & Conditions of Use
  • Forward-Looking Statements
  • Community Guidelines

© 2025 Copyright Chimerix. All rights reserved.

Chimerix is now part of Jazz Pharmaceuticals

Select Jazz for more information about Jazz Pharmaceuticals.
Select continue to proceed to the Chimerix website.

Jazz